Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

OTHER 1 INDUSTRY 1

Study Type

Interventional 1

Sponsor

Conditions

Papillomavirus Infections 1 Intestinal Neoplasms 1 CIN 2/3 1

Interventions

Irinotecan 5 Bevacizumab 5 Leucovorin 4 Fluorouracil 4 5,10-methylenetetrahydrofolic acid 3 Oxaliplatin 2 Levoleucovorin 2 Drug Therapy 2 Cetuximab 2 trametinib 1 spartalizumab 1 repotrectinib 1 pralsetinib 1 pembrolizumab 1 nazartinib 1 napabucasin 1 encorafenib 1 canakinumab 1 alectinib 1 Tinzaparin 1 Radiotherapy 1 Pemetrexed 1 Ocoxin 1 Mass Screening 1 KRN-330 1 Folfox protocol 1 Capecitabine 1 Artesunate 1 ABT-165 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

INDUSTRY × Intestinal Neoplasms × Artesunate × Clear all

NCT07095309 2025-07-31

NeoART-M

Metanoic Health Ltd.

Phase 2 Not yet recruiting

Intestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡